Literature DB >> 956645

Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect.

R P Jacobs, G A Cole.   

Abstract

Primary immunizing infections with LCM virus result in a transient depression of the in vitro proliferative responses of splenic lymphocytes to mitogens specifically reactive with T cells or B cells. This depression of lymphocyte function is the result of a virus-induced defect in an adherent, phagocytic cell population required for in vitro lymphocyte activation. Depressed responses persist for about 1 week after virus clearance and can be corrected by the addition of normal PEM or 2-ME to infected spleen cell cultures. Although the precise nature of this defect remains unclear, it is postulated that it is due to a productive infection of macrophages and their precursors that renders them dysfunctional. Secondary LCM virus infections do not result in depressed in vitro responses to mitogens, presumably because of rapid virus clearance and limited numbers of infected cells. Primary infections of immunologically immature mice, mice rendered functionally athymic, or mice treated with nonspecific immunosuppressive agents result in LCM virus persistence. Shortly after infection, these animals show a similar depression of immunologic reactivity that returns to normal as the virus carrier state becomes established. Despite virus persistence, few PEM from established LCM virus carrier mice contain viral antigens and these cells function normally. Thus, LCM virus-induced immunosuppression appears to reflect a subtle cytopathic effect of LCM virus replication that is not mediated by the virus-specific cell-mediated immune mechanisms responsible for acute LCM virus disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956645

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

2.  Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice.

Authors:  B L Lohman; R M Welsh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.

Authors:  M F Saron; B Shidani; M A Nahori; J C Guillon; P Truffa-Bachi
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Generation in vitro of alloreactive lymphocytes is suppressed by the addition of spleen cells from mice infected with lymphocytic choriomeningitis virus.

Authors:  M Varho-Göbel; G Wolff; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

Review 5.  Virus-induced immunopathology.

Authors:  B T Rouse
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

6.  Lymphocytic choriomeningitis virus-induced immune dysfunction: induction of and recovery from T-cell anergy in acutely infected mice.

Authors:  E A Butz; P J Southern
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Inhibition of mouse peritoneal macrophage DNA synthesis by infection with the arenavirus Pichinde.

Authors:  A M Friedlander; P B Jahrling; P Merrill; S Tobery
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Ia antigens in serum during different murine infections.

Authors:  C R Parish; R R Freeman; I F McKenzie; C Cheers; G A Cole
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

9.  Lymphocytic choriomeningitis virus-induced immunosuppression: evidence for viral interference with T-cell maturation.

Authors:  A R Thomsen; K Bro-Jørgensen; B L Jensen
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Immunosuppressive effect of murine cytomegalovirus.

Authors:  L Loh; J B Hudson
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.